FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891279945> ?p ?o ?g. }

• W2891279945 endingPage "88" @default.
• W2891279945 startingPage "82" @default.
• W2891279945 abstract "In recent decades, the prevalence of hyperuricemia (HU) is increasing worldwide; the role of uric acid (UA) in the genesis of various metabolic disorders, cardiovascular diseases, and kidney disease is being discussed. There are very few investigations of the rate of HU and its role in the development of diseases in certain social groups, including in professional athletes. Objective: to estimate the prevalence of HU and its role in the genesis of various pathological conditions and metabolic disturbances in professional athletes. Patients and methods. A retrospective comparative one-stage study was conducted, for which 2148 athletes who met inclusion criteria were selected and examined in the Federal Research and Clinical Center for Sports Medicine and Rehabilitation, Federal Biomedical Agency, in 2015. A control group consisted of 99 ageand sex-matched healthy volunteers examined at the V.A. Nasonova Research Institute of Rheumatology in 2017. The analysis included a comparison of the rate of HU and other examined parameters in professional athletes and healthy volunteers. The examined parameters were separately compared in athletes with/without HU, followed by statistical processing of results. Results. HU was detected in 306 (14.2%) of the 2148 athletes, more often in men (n=253 (20%) than in women (n=53 (6%); (p<0.001). The rate of HU in the athletes was comparable with that in the healthy population (12.1%). The athletes with HU (n=306) compared with the other athletes (n=1842) had the following statistically higher indicators: the mean serum levels of creatinine, triglycerides, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltranspeptidase, creatinine phosphokinase, and myoglobin, glomerular filtration rate, and body mass index (BMI) (p<0.00001 for all cases). Conclusion. HU is detected quite often in professional athletes (14.2%), which is comparable with the indicators seen in healthy volunteers (12.1%). The high prevalence of HU and its association with indicators reflecting kidney function, lipid metabolic disturbances, and BMI necessitate further investigations aimed at searching the causes of HU and methods of its prevention and treatment in professional athletes." @default.
• W2891279945 created "2018-09-27" @default.
• W2891279945 creator A5000913174 @default.
• W2891279945 creator A5008877299 @default.
• W2891279945 creator A5013913301 @default.
• W2891279945 creator A5015975216 @default.
• W2891279945 creator A5017438772 @default.
• W2891279945 creator A5026723367 @default.
• W2891279945 creator A5055177300 @default.
• W2891279945 creator A5075174599 @default.
• W2891279945 creator A5075472187 @default.
• W2891279945 creator A5082675227 @default.
• W2891279945 date "2018-09-16" @default.
• W2891279945 modified "2023-09-26" @default.
• W2891279945 title "Prevalence of hyperuricemia in professional athletes and its role in the genesis of various pathological conditions and metabolic disturbances" @default.
• W2891279945 cites W1490020893 @default.
• W2891279945 cites W1519871258 @default.
• W2891279945 cites W1549899683 @default.
• W2891279945 cites W1910948223 @default.
• W2891279945 cites W1964439201 @default.
• W2891279945 cites W2025630123 @default.
• W2891279945 cites W2029481670 @default.
• W2891279945 cites W2034450178 @default.
• W2891279945 cites W2040025341 @default.
• W2891279945 cites W2050828375 @default.
• W2891279945 cites W2058535042 @default.
• W2891279945 cites W2063042771 @default.
• W2891279945 cites W2069400828 @default.
• W2891279945 cites W2071823619 @default.
• W2891279945 cites W2074040634 @default.
• W2891279945 cites W2082358169 @default.
• W2891279945 cites W2086166362 @default.
• W2891279945 cites W2099153645 @default.
• W2891279945 cites W2105450122 @default.
• W2891279945 cites W2112971648 @default.
• W2891279945 cites W2115292404 @default.
• W2891279945 cites W2135099620 @default.
• W2891279945 cites W2154219140 @default.
• W2891279945 cites W2162309758 @default.
• W2891279945 cites W2338911969 @default.
• W2891279945 cites W2513461315 @default.
• W2891279945 cites W2655453243 @default.
• W2891279945 cites W2746018231 @default.
• W2891279945 cites W2757883968 @default.
• W2891279945 cites W2790879686 @default.
• W2891279945 cites W4230870013 @default.
• W2891279945 cites W1989059918 @default.
• W2891279945 doi "https://doi.org/10.14412/1996-7012-2018-3-82-88" @default.
• W2891279945 hasPublicationYear "2018" @default.
• W2891279945 type Work @default.
• W2891279945 sameAs 2891279945 @default.
• W2891279945 citedByCount "3" @default.
• W2891279945 countsByYear W28912799452019 @default.
• W2891279945 countsByYear W28912799452021 @default.
• W2891279945 countsByYear W28912799452022 @default.
• W2891279945 crossrefType "journal-article" @default.
• W2891279945 hasAuthorship W2891279945A5000913174 @default.
• W2891279945 hasAuthorship W2891279945A5008877299 @default.
• W2891279945 hasAuthorship W2891279945A5013913301 @default.
• W2891279945 hasAuthorship W2891279945A5015975216 @default.
• W2891279945 hasAuthorship W2891279945A5017438772 @default.
• W2891279945 hasAuthorship W2891279945A5026723367 @default.
• W2891279945 hasAuthorship W2891279945A5055177300 @default.
• W2891279945 hasAuthorship W2891279945A5075174599 @default.
• W2891279945 hasAuthorship W2891279945A5075472187 @default.
• W2891279945 hasAuthorship W2891279945A5082675227 @default.
• W2891279945 hasBestOaLocation W28912799451 @default.
• W2891279945 hasConcept C126322002 @default.
• W2891279945 hasConcept C1862650 @default.
• W2891279945 hasConcept C2779721657 @default.
• W2891279945 hasConcept C2779881121 @default.
• W2891279945 hasConcept C2779896295 @default.
• W2891279945 hasConcept C2780306776 @default.
• W2891279945 hasConcept C2781054738 @default.
• W2891279945 hasConcept C2908647359 @default.
• W2891279945 hasConcept C42407357 @default.
• W2891279945 hasConcept C43893838 @default.
• W2891279945 hasConcept C71924100 @default.
• W2891279945 hasConcept C99454951 @default.
• W2891279945 hasConceptScore W2891279945C126322002 @default.
• W2891279945 hasConceptScore W2891279945C1862650 @default.
• W2891279945 hasConceptScore W2891279945C2779721657 @default.
• W2891279945 hasConceptScore W2891279945C2779881121 @default.
• W2891279945 hasConceptScore W2891279945C2779896295 @default.
• W2891279945 hasConceptScore W2891279945C2780306776 @default.
• W2891279945 hasConceptScore W2891279945C2781054738 @default.
• W2891279945 hasConceptScore W2891279945C2908647359 @default.
• W2891279945 hasConceptScore W2891279945C42407357 @default.
• W2891279945 hasConceptScore W2891279945C43893838 @default.
• W2891279945 hasConceptScore W2891279945C71924100 @default.
• W2891279945 hasConceptScore W2891279945C99454951 @default.
• W2891279945 hasIssue "3" @default.
• W2891279945 hasLocation W28912799451 @default.
• W2891279945 hasOpenAccess W2891279945 @default.
• W2891279945 hasPrimaryLocation W28912799451 @default.
• W2891279945 hasRelatedWork W2008023095 @default.
• W2891279945 hasRelatedWork W2045146561 @default.
• W2891279945 hasRelatedWork W2060994487 @default.

• next